Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Industries served
- Medical / Health Care
- Monitoring and Testing
- Chemical & Pharmaceuticals
- Water and Wastewater
- Agriculture
- Environmental
- Health and Safety
- Manufacturing, Other
- Food and Beverage
- Defense
- Aerospace & Air Transport
- Glassware
- Paint
- Plastics & Resins
- Waste and Recycling
- Oil, Gas & Refineries
- Air and Climate
- Soil and Groundwater
- University / Academia / Research
- Government
- Energy
Pharma To Accelerate The Development Suppliers In Europe
61 companies found
based inLondon, UNITED KINGDOM
ReGen (Therapeutics Plc) was formed in February 1998 to develop Colostrinin™, a proline-rich polypeptide complex derived from mammalian colostrum. Colostrinin™ is promoted as having utility as a support for healthy brain ageing and cognition. ...
ReGen Therapeutics was formed in February 1998 to develop Colostrinin™, a proline-rich polypeptide complex derived from mammalian colostrum. The complex and the peptides within it are viewed as having potential utility in neurodegenerative ...
based inHradec Králové, CZECH REPUBLIC
GENERI BIOTECH was established in 1995, originally as a facility for production of oligonucleotides. We are focusing on R&D, manufacturing and selling of own proprietary products such as real-time PCR CE IVD kits, Life Sciences products and ...
based inBrighton, UNITED KINGDOM
Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention. We have two exciting late-stage clinical assets and a range of earlier research programmes. Our ...
There are two XF-73 dermal programmes in development. One is being run by our China partner and shareholder – China Medical Systems Holdings Limited (CMS) – focused on superficial skin infections and the other is an in-house programme ...
based inLondon, UNITED KINGDOM
Hemogenyx Pharmaceuticals is developing breakthrough therapies for the treatment of blood diseases. Hemogenyx Pharmaceuticals plc is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx ...
Hemogenyx Pharmaceuticals utilizes postnatal human hemogenic endothelial cells (Hu-PHEC cells), discovered by Hemogenyx Pharmaceuticals’ Co-Founder Dr Vladislav Sandler, to generate cancer-free hematopoietic stem cells (HSC) for use in ...
based inKraainem, BELGIUM
With over 17,000 staff in around 200 laboratories across 36 countries, Eurofins Scientific is the world leader in food and biopharma product testing. It is also number one in the world in the field of environmental laboratory services and one of the ...
Complete preclinical service: Early and full drug development is regulatory-driven and complex. The priority in this selection process is to achieve the safety and efficacy of a new molecular entity. The preclinical activity includes mainly safety ...
based inKotlje, SLOVENIA
Castings for food and pharmaceutical industry. Distinctively re-engineer revolutionary meta-services and premium architectures. Intrinsically incubate intuitive opportunities and real-time potentialities. Appropriately communicate one-to-one ...
based inBasel, SWITZERLAND
EsoCap’s vision is to improve the lives of patients affected by esophageal diseases. The esophagus is a particularly challenging environment, as swallowed drugs only remain in the area between the mouth and the stomach for a few seconds. EsoCap, a ...
based inBubendorf, SWITZERLAND
CIS Pharma is an innovator in the life science industry in the field of Oncology and Ophthalmolog. We were awarded with the European Frost & Sullivan Technology Innovation Award for our unique smart polymer technologyœ, says Christoph Schäfer, CEO ...
CIS Pharma develops novel antibody-drug- conjugates (ADCs) based on our proprietary polymer carrier platform. Our polymers serve as carriers that are loaded with cytotoxic drugs, radioisotopes or other active entities. The carrier together with its ...
based inAndernach, GERMANY
Since 1984 we have been focused on utilizing our expertise, experience and innovation to create market leading drug delivery solutions for our pharmaceutical partners. As a trusted technology partner for the pharmaceutical industry, we develop and ...
based inDen HaagAshford, NETHERLANDS
Royal Imtech N.V. is a European technical services provider in the fields of electrical solutions, ICT (information and communication technology) and mechanical solutions. With 30,000 employees, Imtech achieves annual revenue of more than 5.4 ...
based inSaint-Maur-des-Fossés, FRANCE
Since its foundation in 1932, Septodont has been at the forefront of pharmaceutical dentistry developing, manufacturing and distributing a wide range of high quality dental products all over the world. Looking to the future, Septodont is also ...
Innovation is part of our company’s identity and we continuously strive to bring new solutions to the markets we serve. In that perspective and based on our core competencies in injectable and semi-solid pharmaceutical manufacturing, research ...
based inGuildford, UNITED KINGDOM
Futura Medical is a pharmaceutical company developing a portfolio of innovative products based on our proprietary, transdermal DermaSys technology. Futura Medical is an innovative R&D company with a pipeline of products in late stage development. ...
Joint venture collaboration. Early development stage completed. IP application filed. Advisers retained to explore commercial ...
based inBerlin, GERMANY
ALBEGA Medical is a newly established pharmaceutical company developing novel radiopharmaceuticals in oncology. Our lead compound is Tetrofosmin (TTF) that we are developing in 3 indications: GLIOTECT - a novel diagnostic for brain tumors, GLIOTHER ...
based inSpianate Altopascio, ITALY
With over 40 years in operation, CO.RA. srl specializes in providing systems for intercepting, dosing, regulating, and transporting solid products like powders, tablets, capsules, and granules across chemical, pharmaceutical, food, and cosmetics ...
based inBalerna, SWITZERLAND
APR Applied Pharma Research s.a. (APR) is a Swiss Pharma company dedicated to providing patients suffering from rare diseases with innovative treatments that make a real difference in their life. Our focus as a Swiss global health care company is ...
based inFlintshire, UNITED KINGDOM
Quay Pharma is an independent, privately owned contract development manufacturing organisation (CDMO). Since 2002 we have proudly delivered over 250 successful projects and exercised continued improvement whilst remaining true to our core values. ...
Quay Pharma is widely recognised as leading experts in all aspects of pharmaceutical development and dosage form optimisation for a wide range of product types, including those that have poor solubility or ...
based inLYON, FRANCE
Founded in December 2013, Adjuvatis is specialized in the development, manufacturing and formulation of a safe-by-design delivery system, called i-Particles®. Based on fully metabolizable ans biocompatible particles, this technology was initially ...
based inStockholm, SWEDEN
IBT is a pharmaceutical company with its registered office in Stockholm with a vision to develop drugs influencing the human infant microbiome, and thereby prevent or treat rare diseases affecting premature infants. IBT is currently developing its ...
IBP-9414 for the prevention of necrotizing enterocolitis (NEC) contains the active substance Lactobacillus reuteri, which is a co-evolved human bacterial strain naturally present in breast milk. Lactobacillus reuteri is a live bacteria known to be ...
based inStockholm, SWEDEN
Recipharm develops and manufactures inhalation products and devices including integrated drug solutions, medical check valves and injection devices. Whether you’re a big pharma company outsourcing a key stage of your production or a small to medium ...
based inBasel, SWITZERLAND
T3 Pharmaceuticals was founded in May 2015 by Simon Ittig, Christoph Kasper, Marlise Amstutz and Helmut Kessmann as a spin-off of the University of Basel. The team has developed an efficient protein delivery technology that is based on the use of ...
T3 Pharma has developed a proprietary cancer therapy platform based on regulating and harnessing the natural behaviours of live bacteria. The genetically engineered bacteria selectively target solid tumors, where they deliver chosen protein payloads ...
